Intrinsiqq
Rezolute, Inc. logo

Rezolute, Inc. Insider Trading

RZLT

Compare
Last 12 months

Insiders bought 236K on the open market and sold nothing.

Net open-market
+236K
6 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
5 / 0
executives and directors
Last open-market buy
Mar 2026
Mar 30, 2026

Get an email when RZLT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Mar 30
    Daron Evans
    CFO · bought 10,000 at $2.85
    29K
    2.0% of stake
  • Dec 16, 2025
    Wladimir Hogenhuis
    Director · bought 5,650 at $1.69
    10K
    5.0% of stake
  • Dec 16, 2025
    Brian Kenneth Roberts
    Chief Medical Officer · bought 28,000 at $1.70
    48K
    9.5% of stake
  • Dec 15, 2025
    Daron Evans
    CFO · bought 45,000 at avg $1.77
    80K
    9.6% of stake
  • Dec 15, 2025
    Nevan C Elam
    CEO · bought 32,000 at $1.59
    51K
    5.3% of stake
  • Dec 15, 2025
    Sunil Ratilal Karnawat
    Chief Commercial Officer · bought 12,100 at avg $1.62
    20K
    17% of stake
  • Jun 25, 2025
    Brian Kenneth Roberts
    Chief Medical Officer · bought 2,500 at $4.38
    11K
    17% of stake
  • Jun 24, 2025
    Daron Evans
    CFO · bought 5,000 at $4.05
    20K
    1.4% of stake
  • Jun 13, 2025
    Young-Jin Kim
    Director · bought 1,230,769 at $3.25
    $4M
    17% of stake
  • Jun 13, 2025
    Nerissa Kreher
    Director · bought 3,076 at $3.25
    10K
    8.9% of stake
  • Mar 31, 2025
    Wladimir Hogenhuis
    Director · bought 6,758 at $2.92
    20K
    8.7% of stake
  • Mar 27, 2025
    Nevan C Elam
    CEO · bought 12,302 at $2.85
    35K
    5.8% of stake
  • Mar 26, 2025
    Daron Evans
    CFO · bought 20,000 at avg $2.89
    58K
    6.5% of stake
  • Feb 18, 2025
    Wladimir Hogenhuis
    Director · bought 10,000 at $4.70
    47K
    15% of stake
  • Dec 18, 2024
    Daron Evans
    CFO · bought 10,000 at $4.29
    43K
    4.5% of stake
  • Dec 12, 2024
    Daron Evans
    CFO · bought 9,000 at $4.60
    41K
    4.2% of stake
  • Dec 10, 2024
    Daron Evans
    CFO · bought 10,549 at $5.04
    53K
    5.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch RZLT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with RZLT

CompareIntrinsic value
AVTXAvalo Therapeutics Inc.
$6.76+0.15%10
CTMXCytomX Therapeutics Inc.
$2.03-0.98%10
PRTAProthena Corporation plc
$8.22-2.14%25
GYREGyre Therapeutics Inc.
$4.21-6.86%18
STTKShattuck Labs Inc.
$4.46-1.98%25
NGNENeurogene Inc.
$22.15-3.40%10
ACRSAclaris Therapeutics, Inc.
$3.44-1.71%10
JANXJanux Therapeutics Inc.
$10.08-2.04%40

Held by ETFs

RZLT is in 13 US ETFs. The largest of them, with RZLT's weight in each:

Spot a number that looks wrong? Check it in RZLT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing RZLT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.